Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Routine use of Hib vaccine could lead to virtual elimination of killer disease in Africa

10.08.2006
Saving children’s lives: Kenyan study confirms plummeting rates of Hib disease
The Journal of the American Medical Association (JAMA) today publishes research showing that routine vaccination of infants in Kenya against H. influenzae Type b (Hib) significantly reduced invasive Hib disease to 88% below baseline.

The paper, entitled: Effectiveness of Haemophilus influenzae Type b (Hib) Conjugate Vaccine Introduction into Routine Childhood Immunization in Kenya, was authored by a team led by Oxford University's Dr. Anthony Scott. Three years after introduction, Hib vaccination was responsible for:

  • Reducing laboratory-confirmed invasive Hib disease by 88% from pre-vaccine levels
  • Preventing an estimated 3,370 hospitalizations in Kenya in 2005

Commenting on the study, Karen Cowgill, lead author and, at the time of the study, Epidemic Intelligence Service officer at the Centers for Disease Control and Prevention in the US, said: "These results demonstrate the effectiveness of the Hib vaccine in reducing severe childhood illness and associated deaths in Kenya, and lead us to conclude that many more deaths could be averted in Africa if more countries were to adopt the vaccine as part of their national EPI programs."

This is the first published study in East Africa to document the significant benefit of routine Hib vaccination in protecting young children against the devastating effects of a leading cause of childhood meningitis and pneumonia. The findings build on a considerable body of growing evidence from Africa and around the world: similar results have been observed in The Gambia, Chile, the US, and UK. The findings contained within the study can reasonably be expected to apply to other African settings too.

Recently, a number of developing countries have begun routinely vaccinating children against Hib disease. Yet despite the overwhelming evidence and support in favor of these vaccines, less than 40% of African countries have adopted the Hib vaccine. One major obstacle has been the lack of available data on Hib disease burden and vaccine effectiveness.

"It is vital to support public health interventions such as the introduction of Hib vaccine with hard evidence", said Dr. Sharif, Deputy Director of Medical Services within the Ministry of Health, Kenya. "The strength of our surveillance systems will also assist us with the evaluation of new vaccines to prevent other leading child killers such as pneumococcus and rotavirus", he added.

Worldwide, Hib disease is estimated to cause 3 million episodes of serious disease among children each year, leading to 400,000 deaths. The greatest burden of disease and death occurs in Africa. If countries, donors and industry can be mobilized to introduce Hib vaccine into the countries that need it the most, the parents, children and healthcare providers in Africa could see the same virtual elimination of this devastating disease as seen in industrialized countries

Surveillance to monitor the impact of health and vaccination programs is essential. "Building the evidence base for the introduction of new and underused life-saving vaccines is a critical step in understanding what interventions countries need to save more lives faster", said Julian Lob-Levyt, Executive Secretary, GAVI Alliance. "If you can measure the impact a disease is having on your country, it is easier to build the case for preventing it", he added.

The GAVI Alliance, together with partners and stakeholders in Kenya and other developing countries, is working collaboratively to provide funding for vaccine programs and to implement programs to improve health systems and strengthen surveillance networks.

This study further supports the WHO's Strategic advisory Group of Experts (SAGE) and Africa's Task Force on Immunization's recommendations for global implementation of Hib vaccine and suggests that routine use could help reach the Millennium Development Goal of reducing child mortality by two-thirds by 2015.

Lois Privor-Dumm | EurekAlert!
Further information:
http://www.jhsph.edu

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>